NIH-funded research R01 grant

Genes linked to early thinking and memory decline before dementia

Official title: Large-Scale Genomic Analysis of Aging-Related Cognitive Change Prior to Dementia Onset

Funded at University of Texas at Austin · NIH-11128831 · Data updated 2026-11-12

Researchers are looking at people's genes to find changes tied to earlier declines in memory and thinking before Alzheimer's develops.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas at Austin
NIH-funded
Lab location1 site (Austin, United States)
Project startAugust 15, 2021
Project endJuly 31, 2026
Funding year2025
Award (this year)$622,383
NIH project number5R01AG073593-03
Project IDNIH-11128831 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants are adults who can provide genetic samples and have (or can provide access to) repeated cognitive test results over time, especially older adults or those with a family history of Alzheimer's.

Less likely to help

People without genetic data or long-term cognitive testing, or whose memory problems are caused by non-Alzheimer conditions, may not see direct benefit from this work.

What this research studies

If you join, researchers will analyze genetic data together with long-term memory and thinking test results from many adults to find patterns tied to faster cognitive decline years before dementia appears. They will use repeated cognitive measurements over time rather than single checkups and apply large-scale genome-wide analyses to search for risk variants beyond the well-known APOE gene. The team will use statistical methods to account for differences in people's peak thinking ability so declines aren't missed in those who started at a higher level. The work draws on large datasets from multiple cohorts to identify biological pathways that could be targeted for earlier prevention.

Why it matters

Potential benefit: Could help identify people at higher risk earlier and point to new biological targets to prevent or slow Alzheimer's and related dementias.

How similar studies have gone: Prior genetic studies have reliably linked APOE and several other loci to Alzheimer's risk, but large-scale GWAS focused on long-term cognitive decline before diagnosis is a newer approach with limited prior results.

Where this research is happening

  • University of Texas at Austin
    Austin, United States
    Active

Researchers

  • Principal investigator: Tucker-Drob, Elliot Max — University of Texas at Austin
  • Study coordinator: Tucker-Drob, Elliot Max

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.